BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38797233)

  • 1. Crosstalk between the nervous system and tumor microenvironment: Functional aspects and potential therapeutic strategies.
    Wang L; Ge J; Han H; Jia Y; Qin Y
    Cancer Lett; 2024 Jul; 594():216986. PubMed ID: 38797233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active autophagy in cancer-associated fibroblasts: Recent advances in understanding the novel mechanism of tumor progression and therapeutic response.
    Jena BC; Rout L; Dey A; Mandal M
    J Cell Physiol; 2021 Nov; 236(11):7887-7902. PubMed ID: 34008184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
    Akkız H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment.
    Chung JY; Chan MK; Li JS; Chan AS; Tang PC; Leung KT; To KF; Lan HY; Tang PM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IR-780 Dye-based Targeting of Cancer-associated Fibroblasts Improves Cancer Immunotherapy by Increasing Intra-tumoral T Lymphocytes Infiltration.
    Yang W; Chen Z; Qu L; Zhang C; Chen H; Zheng J; Chen W; Tan X; Shi C
    Curr Cancer Drug Targets; 2024; 24(6):642-653. PubMed ID: 38310462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
    Zhang H; Yue X; Chen Z; Liu C; Wu W; Zhang N; Liu Z; Yang L; Jiang Q; Cheng Q; Luo P; Liu G
    Mol Cancer; 2023 Oct; 22(1):159. PubMed ID: 37784082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAF-immune cell crosstalk and its impact in immunotherapy.
    Maia A; Schöllhorn A; Schuhmacher J; Gouttefangeas C
    Semin Immunopathol; 2023 Mar; 45(2):203-214. PubMed ID: 36480035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts.
    Jung JG; Le A
    Adv Exp Med Biol; 2018; 1063():167-178. PubMed ID: 29946783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy.
    Barrett R; Puré E
    Curr Opin Immunol; 2020 Jun; 64():80-87. PubMed ID: 32402828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
    Piper M; Mueller AC; Karam SD
    Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting.
    Rimal R; Desai P; Daware R; Hosseinnejad A; Prakash J; Lammers T; Singh S
    Adv Drug Deliv Rev; 2022 Oct; 189():114504. PubMed ID: 35998825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.
    De Jaeghere EA; Denys HG; De Wever O
    Trends Cancer; 2019 Nov; 5(11):704-723. PubMed ID: 31735289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators.
    Ilkhani K; Bastami M; Delgir S; Safi A; Talebian S; Alivand MR
    Anticancer Agents Med Chem; 2021; 21(2):254-266. PubMed ID: 32914721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
    Peng Z; Ye M; Ding H; Feng Z; Hu K
    J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal microRNAs mediating crosstalk between cancer cells and cancer-associated fibroblasts in the tumor microenvironment.
    Wang Y; Liang H; Zheng J
    Pathol Res Pract; 2022 Nov; 239():154159. PubMed ID: 36244248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.